help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, V. E.
Right arrow Articles by Clifton, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, V. E.
Right arrow Articles by Clifton, V. L.
Right arrowPubmed/NCBI databases
*OMIM
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Asthma
*High Risk Pregnancy
Hazardous Substances DB
*HYDROCORTISONE
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 4 1660-1668
Copyright © 2002 by The Endocrine Society


Other Original Articles

Reduced 11ß-Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated with Decreased Birth Weight Centile in Pregnancies Complicated by Asthma

Vanessa E. Murphy, Tamas Zakar, Roger Smith, Warwick B. Giles, Peter G. Gibson and Vicki L. Clifton

Mothers and Babies Research Centre (V.E.M., T.Z., R.S., W.B.G., V.L.C.), University of Newcastle; and Department of Respiratory and Sleep Medicine (P.G.G.), John Hunter Hospital, Newcastle, New South Wales 2310, Australia

Address all correspondence and requests for reprints to: Dr.Vicki Clifton, Mothers and Babies Research Centre, Endocrine Unit, John Hunter Hospital, Locked Bag 1, Hunter Region Mail Center, Newcastle, New South Wales, 2310, Australia. E-mail: . vclifton{at}mail.newcastle.edu.au

Abstract

Pregnancies complicated by asthma are associated with an increased risk of low birth weight. Currently, the mechanisms causing this outcome are unknown. To investigate whether impaired placental function may be a determinant, we measured placental 11ß-hydroxysteroid dehydrogenase type 2 (11ß-HSD2) activity, protein and mRNA, placental CRH mRNA, fetal cortisol, and fetal estriol concentrations at delivery.

Asthmatic subjects were classified according to inhaled glucocorticoid intake during pregnancy and compared with a control nonasthmatic group. There was a 25% reduction in neonatal birth weight centile in asthmatic women who did not use inhaled glucocorticoid treatment. This was accompanied by significantly reduced placental 11ß-HSD2 activity, significantly increased fetal cortisol, and a trend toward increased placental CRH mRNA and reduced fetal estriol concentrations. The use of inhaled glucocorticoids for treatment was associated with birth weight centile, 11ß-HSD2 activity, CRH mRNA, fetal cortisol, and estriol concentrations similar to control levels. There was a significant inverse correlation between fetal cortisol and fetal estriol concentrations across all groups.

These studies demonstrate that inhaled glucocorticoid intake for the treatment of asthma is associated with improved placental function and fetal outcome, suggesting that inflammatory factors associated with asthma may be detrimental to fetal growth and development in these pregnancies.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Sharma, H. Guan, and K. Yang
The p38 Mitogen-Activated Protein Kinase Regulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 (11{beta}-HSD2) Expression in Human Trophoblast Cells through Modulation of 11{beta}-HSD2 Messenger Ribonucleic Acid Stability
Endocrinology, September 1, 2009; 150(9): 4278 - 4286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Stark, I. M. R. Wright, and V. L. Clifton
Sex-specific alterations in placental 11{beta}-hydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R510 - R514.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. S. Wyrwoll, J. R. Seckl, and M. C. Holmes
Altered Placental Function of 11{beta}-Hydroxysteroid Dehydrogenase 2 Knockout Mice
Endocrinology, March 1, 2009; 150(3): 1287 - 1293.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. M. Scott, N. A. Hodyl, V. E. Murphy, A. Osei-Kumah, H. Wyper, D. M. Hodgson, R. Smith, and V. L. Clifton
Placental Cytokine Expression Covaries with Maternal Asthma Severity and Fetal Sex
J. Immunol., February 1, 2009; 182(3): 1411 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
A. E. Michael and A. T. Papageorghiou
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. C. Holmes, C. T. Abrahamsen, K. L. French, J. M. Paterson, J. J. Mullins, and J. R. Seckl
The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids.
J. Neurosci., April 5, 2006; 26(14): 3840 - 3844.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Yang, L. Julan, F. Rubio, A. Sharma, and H. Guan
Cadmium reduces 11{beta}-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E135 - E142.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V. E. Murphy, P. G. Gibson, P. I. Talbot, C. G. Kessell, and V. L. Clifton
Asthma self-management skills and the use of asthma education during pregnancy
Eur. Respir. J., September 1, 2005; 26(3): 435 - 441.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
V. E. Murphy, R. F. Johnson, Y.-C. Wang, K. Akinsanya, P. G. Gibson, R. Smith, and V. L. Clifton
The Effect of Maternal Asthma on Placental and Cord Blood Protein Profiles
Reproductive Sciences, July 1, 2005; 12(5): 349 - 355.
[Abstract] [PDF]


Home page
Eur Respir JHome page
V. E. Murphy, P. G. Gibson, R. Smith, and V. L. Clifton
Asthma during pregnancy: mechanisms and treatment implications
Eur. Respir. J., April 1, 2005; 25(4): 731 - 750.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. E. Murphy, P. G. Gibson, W. B. Giles, T. Zakar, R. Smith, A. M. Bisits, C. G. Kessell, and V. L. Clifton
Maternal Asthma Is Associated with Reduced Female Fetal Growth
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1317 - 1323.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society